Stefan Gazdzinski1, John Kornak, Michael W Weiner, Dieter J Meyerhoff. 1. Center for Imaging of Neurodegenerative Diseases, San Francisco Veterans Administration Medical Center, University of California San Francisco, San Francisco, CA 94121, USA. stefan.gazdzinski@ucsf.edu
Abstract
OBJECTIVE: Obesity and being overweight during adulthood have been consistently linked to increased risk for development of dementia later in life, especially Alzheimer's disease. They have also been associated with cognitive dysfunction and brain structural alterations in otherwise healthy adults. Although proton magnetic resonance spectroscopy may distinguish between neuronal and glial components of the brain and may point to neurobiological mechanisms underlying brain atrophy and cognitive changes, no spectroscopic studies have yet assessed the relationships between adiposity and brain metabolites. METHODS: We have utilized magnetic resonance imaging and proton magnetic resonance spectroscopic imaging data from 50 healthy middle-aged participants (mean age, 41.7 +/- 8.5 years; 17 women), who were scanned as control subjects for another study. RESULTS: After adjustment for age and sex, greater body mass indices (BMIs) correlated with: (1) lower concentrations of N-acetylaspartate (spectroscopic marker of neuronal viability) in frontal (p = 0.001), parietal (p = 0.006), and temporal (p = 0.008) white matter; (2) lower N-acetylaspartate in frontal gray matter (p = 0.01); and (3) lower concentrations of choline-containing metabolites (associated with membrane metabolism) in frontal white matter (p = 0.05). INTERPRETATION: These results suggest that increased BMI at midlife is associated with neuronal and/or myelin abnormalities, primarily in the frontal lobe. Because white matter in the frontal lobes is more prone to the effects of aging than in other lobes, our results may reflect accelerated aging in individuals with high levels of adiposity. Thus, greater BMI may increase the odds of developing an age-related disease, such as Alzheimer's disease.
OBJECTIVE: Obesity and being overweight during adulthood have been consistently linked to increased risk for development of dementia later in life, especially Alzheimer's disease. They have also been associated with cognitive dysfunction and brain structural alterations in otherwise healthy adults. Although proton magnetic resonance spectroscopy may distinguish between neuronal and glial components of the brain and may point to neurobiological mechanisms underlying brain atrophy and cognitive changes, no spectroscopic studies have yet assessed the relationships between adiposity and brain metabolites. METHODS: We have utilized magnetic resonance imaging and proton magnetic resonance spectroscopic imaging data from 50 healthy middle-aged participants (mean age, 41.7 +/- 8.5 years; 17 women), who were scanned as control subjects for another study. RESULTS: After adjustment for age and sex, greater body mass indices (BMIs) correlated with: (1) lower concentrations of N-acetylaspartate (spectroscopic marker of neuronal viability) in frontal (p = 0.001), parietal (p = 0.006), and temporal (p = 0.008) white matter; (2) lower N-acetylaspartate in frontal gray matter (p = 0.01); and (3) lower concentrations of choline-containing metabolites (associated with membrane metabolism) in frontal white matter (p = 0.05). INTERPRETATION: These results suggest that increased BMI at midlife is associated with neuronal and/or myelin abnormalities, primarily in the frontal lobe. Because white matter in the frontal lobes is more prone to the effects of aging than in other lobes, our results may reflect accelerated aging in individuals with high levels of adiposity. Thus, greater BMI may increase the odds of developing an age-related disease, such as Alzheimer's disease.
Authors: Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London Journal: Biol Psychiatry Date: 2004-01-01 Impact factor: 13.382
Authors: Jürgen Gallinat; Undine E Lang; Leslie K Jacobsen; Malek Bajbouj; Peter Kalus; Dorothea von Haebler; Frank Seifert; Florian Schubert Journal: J Clin Psychopharmacol Date: 2007-02 Impact factor: 3.153
Authors: J O'Neill; J L Eberling; N Schuff; W Jagust; B Reed; G Soto; F Ezekiel; G Klein; M W Weiner Journal: Magn Reson Med Date: 2000-02 Impact factor: 4.668
Authors: Xiaoping Zhu; Norbert Schuff; John Kornak; Brian Soher; Kristine Yaffe; Joel H Kramer; Frank Ezekiel; Bruce L Miller; William J Jagust; Michael W Weiner Journal: Alzheimer Dis Assoc Disord Date: 2006 Apr-Jun Impact factor: 2.703
Authors: Yair Safriel; Marlyanne Pol-Rodriguez; Edward J Novotny; Douglas L Rothman; Robert K Fulbright Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825
Authors: D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: Lidia M Nagae-Poetscher; David Bonekamp; Peter B Barker; Larry J Brant; Walter E Kaufmann; Alena Horská Journal: J Magn Reson Imaging Date: 2004-01 Impact factor: 4.813
Authors: Annadora J Bruce-Keller; Christy L White; Sunita Gupta; Alecia G Knight; Paul J Pistell; Donald K Ingram; Christopher D Morrison; Jeffrey N Keller Journal: Free Radic Biol Med Date: 2010-03-25 Impact factor: 7.376
Authors: Christy L White; Paul J Pistell; Megan N Purpera; Sunita Gupta; Sun-Ok Fernandez-Kim; Taylor L Hise; Jeffrey N Keller; Donald K Ingram; Christopher D Morrison; Annadora J Bruce-Keller Journal: Neurobiol Dis Date: 2009-04-15 Impact factor: 5.996
Authors: Cyrus A Raji; April J Ho; Neelroop N Parikshak; James T Becker; Oscar L Lopez; Lewis H Kuller; Xue Hua; Alex D Leow; Arthur W Toga; Paul M Thompson Journal: Hum Brain Mapp Date: 2010-03 Impact factor: 5.038
Authors: Michael Ewers; Susanne Schmitz; Oskar Hansson; Cathal Walsh; Annette Fitzpatrick; David Bennett; Lennart Minthon; John Q Trojanowski; Leslie M Shaw; Yetunde O Faluyi; Bruno Vellas; Bruno Dubois; Kaj Blennow; Katharina Buerger; Stefan J Teipel; Michael Weiner; Harald Hampel Journal: Neurobiol Aging Date: 2011-06-17 Impact factor: 4.673
Authors: Paul J Pistell; Christopher D Morrison; Sunita Gupta; Alecia G Knight; Jeffrey N Keller; Donald K Ingram; Annadora J Bruce-Keller Journal: J Neuroimmunol Date: 2009-12-08 Impact factor: 3.478